{"id":"W3080216678","doi":"10.1200/jco.2009.27.15_suppl.5559","title":"A phase II trial of voreloxin in women with platinum-resistant ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Neutropenia; Internal medicine; Nausea; Febrile neutropenia; Ovarian cancer; Regimen; Dosing; Cancer; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006705543,0.0005728206,0.0009426241,0.0002398878,0.0002877328,0.0004452297,0.00037727,0.000827484,0.005943618],"category_scores_gemma":[0.0006567764,0.0003295314,0.0004671022,0.000244143,0.0003597387,0.0003330745,0.000304656,0.001398346,0.0008661576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004540232,"about_ca_system_score_gemma":0.000854793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008273874,"about_ca_topic_score_gemma":0.00229753,"domain_scores_codex":[0.9998448,0.00007121186,0.000009716177,0.00003128468,0.0000127912,0.00003022073],"domain_scores_gemma":[0.9997109,0.00005750642,0.00004075281,0.00001897037,0.00001443415,0.0001574274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6842538,0.04134852,0.01296945,0.001443737,0.001118492,0.0005341284,0.0004799141,0.002594238,0.0442389,0.0006382853,0.009807985,0.2005726],"study_design_scores_gemma":[0.6594105,0.3076004,0.023446,0.00007119523,0.0003059992,0.0003471055,0.00008527139,0.0009899319,0.001503329,0.0002953148,0.005925565,0.00001945534],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890803,0.002422623,0.0003362511,0.0007987586,0.0001578393,0.002960942,0.0009973586,0.00006167727,0.003184233],"genre_scores_gemma":[0.9870982,0.002276454,0.0009672505,0.001415165,0.0001434528,0.00223321,0.002316103,0.00001340803,0.003536758],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005943618,"threshold_uncertainty_score":0.01988339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06228219875772464,"score_gpt":0.4404323721857346,"score_spread":0.3781501734280099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}